Javascript must be enabled to continue!
Photodegradation kinetics of Bilastine in tablets
View through CrossRef
Photodegradation is the process by which a chemical substance is broken down through exposure to light, typically ultraviolet (UV) radiation. This process is significant in environmental chemistry, where sunlight can degrade pollutants and materials, influencing their persistence and toxicity. Bilastine is a novel non-sedating histamine H1-receptor antagonist developed for the treatment of allergic rhino conjunctivitis and urticaria. The literature presents some studies on the quantitative determination of bilastine by high-performance liquid chromatography in pharmaceutical forms and biological fluids, however, no data on the photodegradation kinetics of this drug are described. Therefore, the objective of the study was to determine the photodegradation kinetics of the drug bilastine in coated tablets using a liquid chromatography method previously developed and validated by the same research group (unplished data). The study was carried out with methanolic solution containing 100.0 mg mL-1 of bilastine drug product exposed to UV-C radiation (254 nm). The irradiation of the samples was done at pre-established times: 0, 15, 30, 60, 120 and 180 minutes. The chromatographic separation was performed in a Shim-pack® RP-18 column; the mobile phase comprising a mixture of 0.3% triethylamine (pH adjusted to 6.0 with 20% formic acid) and acetonitrile (66:34, v/v) at a flow-rate of 1.0 mL min-1 with isocratic elution. The temperature was set at 25 °C in the column oven. Bilastine was determined by UV detection at 207 nm using photodiode-array. The results demonstrated that the photodegradation kinetics of bilastine in methanolic solution follows the first order of reaction, with a t90% of 27.11 minutes and degradation rate constant (k) of 0.0007 min-1.
Universidade Federal do Rio Grande do Sul
Title: Photodegradation kinetics of Bilastine in tablets
Description:
Photodegradation is the process by which a chemical substance is broken down through exposure to light, typically ultraviolet (UV) radiation.
This process is significant in environmental chemistry, where sunlight can degrade pollutants and materials, influencing their persistence and toxicity.
Bilastine is a novel non-sedating histamine H1-receptor antagonist developed for the treatment of allergic rhino conjunctivitis and urticaria.
The literature presents some studies on the quantitative determination of bilastine by high-performance liquid chromatography in pharmaceutical forms and biological fluids, however, no data on the photodegradation kinetics of this drug are described.
Therefore, the objective of the study was to determine the photodegradation kinetics of the drug bilastine in coated tablets using a liquid chromatography method previously developed and validated by the same research group (unplished data).
The study was carried out with methanolic solution containing 100.
0 mg mL-1 of bilastine drug product exposed to UV-C radiation (254 nm).
The irradiation of the samples was done at pre-established times: 0, 15, 30, 60, 120 and 180 minutes.
The chromatographic separation was performed in a Shim-pack® RP-18 column; the mobile phase comprising a mixture of 0.
3% triethylamine (pH adjusted to 6.
0 with 20% formic acid) and acetonitrile (66:34, v/v) at a flow-rate of 1.
0 mL min-1 with isocratic elution.
The temperature was set at 25 °C in the column oven.
Bilastine was determined by UV detection at 207 nm using photodiode-array.
The results demonstrated that the photodegradation kinetics of bilastine in methanolic solution follows the first order of reaction, with a t90% of 27.
11 minutes and degradation rate constant (k) of 0.
0007 min-1.
Related Results
A Validated Stability Indicating HPTLC Method for Bilastine and Montelukast in Pharmaceutical Dosage Form
A Validated Stability Indicating HPTLC Method for Bilastine and Montelukast in Pharmaceutical Dosage Form
An accurate and precise and robust method has been described for Stability Indicating HPTLC method for development and validation for Bilastine and Montelukast in pharmaceutical do...
DEVELOPMENT AND VALIDATION OF RP-HPLC BASED ANALYTICAL METHOD FOR SIMULTANEOUS ESTIMATION OF MONTELUKAST AND BILASTINE IN TABLET DOSAGE FORM
DEVELOPMENT AND VALIDATION OF RP-HPLC BASED ANALYTICAL METHOD FOR SIMULTANEOUS ESTIMATION OF MONTELUKAST AND BILASTINE IN TABLET DOSAGE FORM
A new RP-HPLC method was developed for the estimation of bilastine and montelukast in tablets and it was validated as per ICH guidelines. The chromatogram for was found to be satis...
Pharmacological profile of antihistamines: focus on unwanted drug interactions
Pharmacological profile of antihistamines: focus on unwanted drug interactions
Differences between individual antihistamines are determined by such pharmacokinetic properties as the rate and completeness of absorption, half-life, the participation of hepatic ...
Photodegradation Illuminated
Photodegradation Illuminated
The study of photodegradation processes concerns many fields, including those of cultural heritage, the food industry, and water purification. In each of these areas, different que...
A highly sensitive spectrofluorimetric method for the determination of bilastine in human plasma: Application of content uniformity testing
A highly sensitive spectrofluorimetric method for the determination of bilastine in human plasma: Application of content uniformity testing
AbstractBilastine, a new second generation antihistaminic drug, has been widely used for relieving symptoms of allergic rhinitis and urticaria without a sedative effect. A simple, ...
Efficacy of Bilastine in the Management of Urticaria- A Retrospective Study
Efficacy of Bilastine in the Management of Urticaria- A Retrospective Study
Background: Urticaria or hives is a common skin condition with a lifetime prevalence of 7.8–22.3%, a point prevalence of 0.5- 1.0%. This study focuses to determine the efficacy of ...
Development and Validation of RP-HPLC Method for the Simultaneous Estimation of Bilastine and Montelukast in Tablet Dosage Form
Development and Validation of RP-HPLC Method for the Simultaneous Estimation of Bilastine and Montelukast in Tablet Dosage Form
Place of Study: Department of Pharmacy, University College of Technology, Osmania University, Hyderabad, Telangana.
Aim: The present study is describing about the development of a...
Shared decision-making in opioid prescribing for minimally invasive hysterectomy: A prospective randomized controlled trial
Shared decision-making in opioid prescribing for minimally invasive hysterectomy: A prospective randomized controlled trial
Objective: To determine the impact of shared decision-making in postsurgical opioid prescribing in women who underwent minimally invasive (MIS) hysterectomy.Design: A randomized co...

